MyFinsight
Home
Blog
About
Non Us
$7,377M
(7.44%↑ Y/Y)
US
$5,216M
(21.98%↑ Y/Y)
Net sales
$12,593M
(13.02%↑ Y/Y)
Operating earnings
$1,693M
(-17.50%↓ Y/Y)
Other (income)
expense, net
$134M
(-2.19%↓ Y/Y)
Interest (income)
$52M
(-26.76%↓ Y/Y)
Total operating cost
and expenses
$10,900M
(19.91%↑ Y/Y)
Earnings before taxes
$1,524M
(-29.12%↓ Y/Y)
Interest expense
$351M
(190.08%↑ Y/Y)
Net foreign
exchange (gain) loss
-$4M
(-136.36%↓ Y/Y)
Cost of products
sold, excluding...
$5,325M
(9.70%↑ Y/Y)
Selling, general, and
administrative
$4,025M
(30.22%↑ Y/Y)
Research and development
$892M
(23.03%↑ Y/Y)
Amortization of intangible
assets
$658M
(56.67%↑ Y/Y)
Net earnings
$928M
(-47.84%↓ Y/Y)
Taxes on earnings
$596M
(60.65%↑ Y/Y)
Back
Back
Income Statement
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
Abbott_Laboratories_logo-svg
ABBOTT LABORATORIES (ABT)
source: myfinsight.com